Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Clearside Biomedical Inc
CLSDCurrent price
0.97 USD
+0.026 USD (+2.73%)
Last closed
0.93 USD
Company
www.clearsidebio.com
ISIN
US1850631045
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
75 493 056 USD
Yield for 12 month
+12.80 %
1Y
3Y
5Y
10Y
15Y
CLSD
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.57 USDP/E ratio
–Dividend Yield
–Current Year
+8 226 000 USD
Last Year
+1 327 000 USD
Current Quarter
+90 000 USD
Last Quarter
+230 000 USD
Current Year
+7 804 000 USD
Last Year
+1 123 000 USD
Current Quarter
+46 000 USD
Last Quarter
+202 000 USD
Key Figures CLSD
1 year
3 years
5 years
10 years
EBITDA
-25 660 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-44.05 %
PEG Ratio
–
Return On Equity TTM
-1310.02 %
Wall Street Target Price
5.57 USD
Revenue TTM
7 524 000 USD
Book Value
-0.38 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-91.2 %
Dividend Yield
–
Gross Profit TTM
1 123 000 USD
Earnings per share
-0.5 USD
Diluted Eps TTM
-0.5 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CLSD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CLSD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CLSD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.2461
Price Sales TTM
10.0336
Enterprise Value EBITDA
-2.8404
Price Book MRQ
3.927
Financials CLSD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLSD
For 52 weeks
0.65 USD
2.12 USD
50 Day MA
1.13 USD
Shares Short Prior Month
206 864
200 Day MA
1.26 USD
Short Ratio
1.04
Shares Short
180 152
Short Percent
0.26 %
BeatStart